サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404586

顔用注射剤の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Hyaluronic Acid), By Application (Facial Line Correction, Face Lift), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 172 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
顔用注射剤の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年11月03日
発行: Grand View Research
ページ情報: 英文 172 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顔用注射剤市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の顔用注射剤市場規模は2023年から2030年にかけて12.0％のCAGRを記録し、2030年までに249億2,000万米ドルに達すると予測されている,顔用注射剤はアンチエイジング治療において極めて重要であり、特に色素沈着や早期老化などのダメージを食い止めるために使用されます。

すべての社会経済的グループで最も人気のある治療はボトックスとフィラーであり、絶大な人気を得ています。

特に新興諸国における外見重視の傾向は、市場を牽引すると予想される主な要因の一つです。加えて、低侵襲処置への消費者の嗜好の変化もまた、市場の成長をサポートすると予想されます。米国形成外科学会（ASPS）によると、2020年に米国で実施された低侵襲手術の上位5つにボツリヌス毒素Aと軟部組織充填剤が入った。

パンデミックの発生により、2020年の第1四半期と第2四半期には、緊急性のない美容整形手術は保留されました。予防措置として当局機関が厳しい制限を課していたため、コロナウイルスの流行は化粧品業界を含むあらゆる業界に影響を及ぼしています。エステティック関連製品のサプライチェーンも影響を受けた。医療機器分野全体の需給チェーンは、パンデミックによって大きく混乱しました。

顔用注射剤市場レポートハイライト

  • 製品タイプ別では、予測期間を通じてA型ボツリヌス毒素セグメントが市場を独占すると予測されます。これは、最も一般的に使用されている低侵襲処置の1つです。
  • 用途別では、フェイスライン矯正分野が市場を独占し、2022年には33.2％の最大収益シェアを占めました。この成長は、フェイスライン、顔のしわ、リップラインなどの美容処置のための顔用注射剤の使用が増加していることによる。
  • 最終用途に基づくと、メッドスパセグメントが市場を独占し、2022年には46.8%の最大収益シェアを占めました。これらの施設では、経験豊富な専門家による顔への注射、非侵襲的な体の輪郭形成、肌の若返り、レーザー治療など、すべての非侵襲的治療が行われています。
  • 北米は、製品の入手が容易で、熟練した外科医が多数存在するため、2022年の売上高シェアは39.7%で市場を独占しました。
  • アジア太平洋地域は、主要な収益創出拠点として機能すると予想されます。この地域はインドのような国々に支えられており、外見への注目が高まっているため、市場にとって有利な機会が生まれると期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の顔用注射剤市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 顔面注射市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 顔用注射剤市場：製品の推定・動向分析

  • 定義と範囲
  • 製品の市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 製品別の世界の顔用注射剤市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 顔用注射剤市場：用途の推定・動向分析

  • 定義と範囲
  • 用途の市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 用途別の世界の顔用注射剤市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 顔用注射剤市場：最終用途の推定・動向分析

  • 定義と範囲
  • 最終用途の市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の注射剤市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第7章 顔用注射剤市場：地域別の推定・動向分析

  • 地域の市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2020年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場規模、予測、数量および動向分析、2018年から2030年：
  • 北米
    • 北米顔用注射剤市場推計・予測、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の顔用注射剤市場推計・予測、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋地域の顔用注射剤市場推計・予測、2018年から2030年
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの顔用注射剤市場推計・予測、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA顔用注射剤市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要メーカーによる最近の開発と影響分析
  • 企業プロファイル（メーカー）
    • Ispen
    • Abbvie（Allergen）
    • Merz Pharma
    • Galderma
    • Revance Therapeutics
    • Sinclair Pharma
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Facial Injectable Market: market outlook
  • Fig. 9 Facial Injectable Market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Global Facial Injectable Market driver impact
  • Fig. 14 Global Facial Injectable Market restraint impact
  • Fig. 15 Global Facial Injectable Market strategic initiatives analysis
  • Fig. 16 Global Facial Injectable Market: Product movement analysis
  • Fig. 17 Global Facial Injectable Market: Product outlook key takeaways
  • Fig. 18 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Poly-L-lactic Acid (PLLA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Global Facial Injectable Market: Application movement analysis
  • Fig. 25 Global Facial Injectable Market: Application outlook and key takeaways
  • Fig. 26 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Lip Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Face Lift market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Acne Scar Treatment Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Global Facial Injectable Market: End-use movement analysis
  • Fig. 33 Global Facial Injectable Market: End-use outlook and key takeaways
  • Fig. 34 Medspas market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Global Facial Injectable Market: regional movement analysis
  • Fig. 38 Global Facial Injectable Market: regional outlook and key takeaways
  • Fig. 39 North America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 France Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Norway Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 China Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 India Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Australia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Thailand Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Middle East and Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Saudi Arabia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 24.92 billion by 2030, registering a CAGR of 12.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.,The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights:

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2022. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 46.8% in 2022. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 39.7% in 2022 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
    • 1.3.6. Data for primary interviews in North America
    • 1.3.7. Data for primary interviews in Europe
    • 1.3.8. Data for primary interviews in Asia Pacific
    • 1.3.9. Data for primary interviews in Latin America
    • 1.3.10. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Approach 1: Commodity flow analysis
    • 1.6.2. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing aging population
      • 3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory constrains
      • 3.2.2.2. High cost of procedures
  • 3.3. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Collagen & PMMA Microspheres
    • 4.1.2. Hyaluronic Acid (HA)
    • 4.1.3. Botulinum Toxin Type A
    • 4.1.4. Calcium Hydroxylapatite (CaHA)
    • 4.1.5. Poly-L-lactic Acid (PLLA)
    • 4.1.6. Others
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Facial Injectable Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Collagen & PMMA Microspheres
      • 4.5.1.1. Collagen & PMMA Microspheres market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.2. Hyaluronic Acid (HA)
      • 4.5.2.1. Hyaluronic Acid (HA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.3. Calcium Hydroxylapatite (CaHA)
      • 4.5.3.1. Calcium Hydroxylapatite (CaHA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.4. Poly-L-lactic Acid (PLLA)
      • 4.5.4.1. Poly-L-lactic Acid (PLLA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Facial Line Correction
    • 5.1.2. Lip Augmentation
    • 5.1.3. Face Lift
    • 5.1.4. Acne Scar Treatment
    • 5.1.5. Lipoatrophy Treatment
    • 5.1.6. Others
  • 5.2. Application Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Facial Injectable Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Facial Line Correction
      • 5.5.1.1. Facial Line Correction market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.2. Lip Augmentation
      • 5.5.2.1. Lip Augmentation market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.3. Face Lift
      • 5.5.3.1. Face Lift market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.4. Acne Scar Treatment
      • 5.5.4.1. Acne Scar Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.5. Lipoatrophy Treatment
      • 5.5.5.1. Lipoatrophy Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Facial Injectable Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Medspas
    • 6.1.2. Dermatology Clinics
    • 6.1.3. Hospitals
  • 6.2. End-use Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Injectable Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Medspas
      • 6.5.1.1. Medspas market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.2. Dermatology Clinics
      • 6.5.2.1. Dermatology Clinics market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.3. Hospitals
      • 6.5.3.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2020
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. North America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
    • 7.7.3. Canada
      • 7.7.3.1. Canada Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
  • 7.8. Europe
    • 7.8.1. Europe Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.2. UK
      • 7.8.2.1. UK Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.2.2. Key Country Dynamics
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Regulatory Framework
    • 7.8.3. Germany
      • 7.8.3.1. Germany Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.3.2. Key Country Dynamics
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Regulatory Framework
    • 7.8.4. France
      • 7.8.4.1. France Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.4.2. Key Country Dynamics
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Regulatory Framework
    • 7.8.5. Italy
      • 7.8.5.1. Italy Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.5.2. Key Country Dynamics
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Regulatory Framework
    • 7.8.6. Spain
      • 7.8.6.1. Spain Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.6.2. Key Country Dynamics
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Regulatory Framework
    • 7.8.7. Sweden
      • 7.8.7.1. Sweden Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.7.2. Key Country Dynamics
      • 7.8.7.3. Competitive Scenario
      • 7.8.7.4. Regulatory Framework
    • 7.8.8. Norway
      • 7.8.8.1. Norway Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.8.2. Key Country Dynamics
      • 7.8.8.3. Competitive Scenario
      • 7.8.8.4. Regulatory Framework
    • 7.8.9. Denmark
      • 7.8.9.1. Denmark Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.9.2. Key Country Dynamics
      • 7.8.9.3. Competitive Scenario
      • 7.8.9.4. Regulatory Framework
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.2. China
      • 7.9.2.1. China Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.2.2. Key Country Dynamics
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Regulatory Framework
    • 7.9.3. Japan
      • 7.9.3.1. Japan Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.3.2. Key Country Dynamics
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. Regulatory Framework
    • 7.9.4. India
      • 7.9.4.1. India Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.4.2. Key Country Dynamics
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Regulatory Framework
    • 7.9.5. Australia
      • 7.9.5.1. Australia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.5.2. Key Country Dynamics
      • 7.9.5.3. Competitive Scenario
      • 7.9.5.4. Regulatory Framework
    • 7.9.6. Thailand
      • 7.9.6.1. Thailand Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.6.2. Key Country Dynamics
      • 7.9.6.3. Competitive Scenario
      • 7.9.6.4. Regulatory Framework
    • 7.9.7. South Korea
      • 7.9.7.1. South Korea Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.7.2. Key Country Dynamics
      • 7.9.7.3. Competitive Scenario
      • 7.9.7.4. Regulatory Framework
  • 7.10. Latin America
    • 7.10.1. Latin America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.2.2. Key Country Dynamics
      • 7.10.2.3. Competitive Scenario
      • 7.10.2.4. Regulatory Framework
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.3.2. Key Country Dynamics
      • 7.10.3.3. Competitive Scenario
      • 7.10.3.4. Regulatory Framework
    • 7.10.4. Argentina
      • 7.10.4.1. Argentina Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.4.2. Key Country Dynamics
      • 7.10.4.3. Competitive Scenario
      • 7.10.4.4. Regulatory Framework
  • 7.11. MEA
    • 7.11.1. MEA Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Saudi Arabia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.2.2. Key Country Dynamics
      • 7.11.2.3. Competitive Scenario
      • 7.11.2.4. Regulatory Framework
    • 7.11.3. South Africa
      • 7.11.3.1. South Africa Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.3.2. Key Country Dynamics
      • 7.11.3.3. Competitive Scenario
      • 7.11.3.4. Regulatory Framework
    • 7.11.4. UAE
      • 7.11.4.1. UAE Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.4.2. Key Country Dynamics
      • 7.11.4.3. Competitive Scenario
      • 7.11.4.4. Regulatory Framework
    • 7.11.5. Kuwait
      • 7.11.5.1. Kuwait Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.5.2. Key Country Dynamics
      • 7.11.5.3. Competitive Scenario
      • 7.11.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company Profiles (Manufacturers)
    • 8.2.1. Ispen
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbvie (Allergen)
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Merz Pharma
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Galderma
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Revance Therapeutics
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Sinclair Pharma
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives